Customs Legislation Amendment (Prohibited Exports and Imports) Regulations 2019 (Cth)
I, General the Honourable David Hurley AC DSC (Retd), Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations.
Dated 12 December 2019
David Hurley
Governor‑General
By His Excellency’s Command
Jason Wood
Assistant Minister for Customs, Community Safety and Multicultural Affairs
Parliamentary Secretary to the Minister for Home Affairs
Contents
This instrument is the
Customs Legislation Amendment (Prohibited Exports and Imports) Regulations 2019 .
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
The whole of this instrument | The day after this instrument is registered. | 17 December 2019 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under the
Customs Act 1901 .
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Repeal the regulation, substitute:
The Minister administering the
Therapeutic Goods Act 1989 may, on the recommendation of the Secretary, by legislative instrument, approve the exportation from Australia of a Schedule 8 drug that meets one or more of the following:
(a) the drug is specified in, or included in a class of drugs specified in, the approval;
(b) the drug is exported in a form (including a concentration) specified in the approval;
(c) the drug is exported by a person, or class of persons, specified in the approval;
(d) the drug does not exceed a value or amount specified in the approval;
(e) the drug is exported in a way, or by a means, specified in the approval.
Insert:
27C | Cyclopropylfentanyl |
Insert:
64A | Methoxyacetylfentanyl |
Insert:
88B | Orthofluorofentanyl |
Insert:
90A | Parafluorobutyrylfentanyl |
Insert:
1AB | ADB‑CHMINACA (otherwise known as MAB‑CHMINACA) |
1AC | ADB‑FUBINACA |
Insert:
6A | CUMYL‑4CN‑BINACA |
Insert:
12AAA | N‑ethylnorpentylone (otherwise known as ephylone) |
Insert:
13AC | FUB‑AMB (otherwise known as MMB‑FUBINACA or AMB‑FUBINACA) |
Insert:
1AA | Alpha‑phenylacetoacetamide (otherwise known as APAA) |
Insert:
17A | 3,4‑MDP‑2‑P methyl glycidate (otherwise known as PMK glycidate) |
17B | 3,4‑MDP‑2‑P methyl glycidic acid (otherwise known as PMK glycidic acid) |
After “a plant”, insert “or part of a plant”.
Repeal the subregulation.
Repeal the subregulation, substitute:
(3) The Minister may, on the recommendation of the Secretary, by legislative instrument, approve the importation into Australia of a drug that meets one or more of the following:
(a) the drug is specified in, or included in a class of drugs specified in, the approval;
(b) the drug is imported in a form (including a concentration) specified in the approval;
(c) the drug is imported by a person, or class of persons, specified in the approval;
(d) the drug does not exceed a value or amount specified in the approval;
(e) the drug is imported in a way, or by a means, specified in the approval.
Repeal the regulations.
16
Subregulation 5HA(1) (paragraph (a) of the definition of Initial decision ) Omit “or 5A(1), (4) or (6)”.
Insert:
The
Customs (Prohibited Imports) (Importation of Hemp Seeds and Hemp Derived Products) Approval 2018 continues in force on and from the commencement of theCustoms Legislation Amendment (Prohibited Exports and Imports) Regulations 2019 (theamending Regulations ) as if it had been made under subregulation 5(3) of this instrument as amended by the amending Regulations.
Insert:
4D | ADB‑CHMINACA (otherwise known as MAB‑CHMINACA) |
4E | ADB‑FUBINACA |
Insert:
11AA | Alpha‑phenylacetoacetamide (otherwise known as APAA) |
Insert:
49FA | CUMYL‑4CN‑BINACA |
Insert:
49H | Cyclopropylfentanyl |
Insert:
87AA | N‑ethylnorpentylone (otherwise known as ephylone) |
Insert:
97DA | FUB‑AMB (otherwise known as MMB‑FUBINACA or AMB‑FUBINACA) |
Insert:
127A | 3,4‑MDP‑2‑P methyl glycidate (otherwise known as PMK glycidate) |
127B | 3,4‑MDP‑2‑P methyl glycidic acid (otherwise known as PMK glycidic acid) |
Insert:
139AB | Methoxyacetylfentanyl |
Insert:
173B | Orthofluorofentanyl |
Insert:
177A | Parafluorobutyrylfentanyl |
Insert:
224A | Thalidomide |
Repeal the item.
Omit all the words after “human consumption that”, substitute “contain calamus or oil of calamus.”.
Repeal the items.
0
0
0